Conclusions: our findings unveil that Eprosartan could serve as a promising therapeutic agent in the context of sepsis-induced AKI.
Abdulredha et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: